Stocks News

LAST PRICE
506.2400
TODAY'S CHANGE (%)
Trending Up0.9000 (0.1781%)

Bid / Lots
505.8200/ 2
Ask / Lots
506.6600/ 4
Open / Previous Close
503.3700 / 505.3400
Day Range
Low 499.1200
High 506.5900
52 Week Range
Low 372.5000
High 583.3900
Volume
109,011
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- BofA Securities Cuts Price Target on IDEXX Laboratories to $595 From $600, Maintains Neutral Rating, from 38 minutes ago by MT Newswires
  38 minutes ago by MT Newswires
  Companies Mentioned: IDXX
  10:02 AM EDT, 04/30/2024 (MT Newswires) -- IDEXX Laboratories (IDXX) has an average outperform rating and a price target range of $400 to $675, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research ...
Apr 4, 2024
- Press Release: IDEXX Laboratories to Release 2024 First Quarter Financial Results, from 4:35PM ET on Thursday Apr 04, 2024 by Dow Jones
  4:35PM ET on Thursday Apr 04, 2024 by Dow Jones
  Companies Mentioned: IDXX
  
  IDEXX Laboratories to Release 2024 First Quarter Financial Results
  WESTBROOK, Maine--(BUSINESS WIRE)--April 04, 2024--
  IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 first quarter results for Wednesday, May 1, 2024, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
- IDEXX Laboratories to Release 2024 First Quarter Financial Results, from 4:30PM ET on Thursday Apr 04, 2024 by Business Wire
  4:30PM ET on Thursday Apr 04, 2024 by Business Wire
  Companies Mentioned: IDXX
  IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 first quarter results for Wednesday, May 1, 2024, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
- IDEXX Laboratories to Release 2024 First Quarter Financial Results, from 4:30PM ET on Thursday Apr 04, 2024 by Dow Jones
  4:30PM ET on Thursday Apr 04, 2024 by Dow Jones
  Companies Mentioned: IDXX
  WESTBROOK, Maine--(BUSINESS WIRE)--April 04, 2024--
  IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 first quarter results for Wednesday, May 1, 2024, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.

Today
- West to Participate in Upcoming Investor Conference, from 4 hours ago by PR Newswire
  4 hours ago by PR Newswire
  Companies Mentioned: WST
Apr 26, 2024
- UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating, from 11:34AM ET on Friday Apr 26, 2024 by MT Newswires
  11:34AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: WST
- Morgan Stanley Adjusts DexCom's Price Target to $132 From $122, from 11:08AM ET on Friday Apr 26, 2024 by MT Newswires
  11:08AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: DXCM
- Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423, from 10:56AM ET on Friday Apr 26, 2024 by MT Newswires
  10:56AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: WST
- Canaccord Genuity Adjusts Price Target on DexCom to $145 From $144, from 10:53AM ET on Friday Apr 26, 2024 by MT Newswires
  10:53AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: DXCM
- Raymond James Adjusts DexCom Price Target to $160 From $151, from 10:25AM ET on Friday Apr 26, 2024 by MT Newswires
  10:25AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: DXCM
- Align Technology to Buy Back $150 Million in Shares, from 10:05AM ET on Friday Apr 26, 2024 by MT Newswires
  10:05AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: ALGN
- Align Technology Announces $150 Million Open Market Repurchase, from 8:30AM ET on Friday Apr 26, 2024 by Business Wire
  8:30AM ET on Friday Apr 26, 2024 by Business Wire
  Companies Mentioned: ALGN
Apr 25, 2024
- DexCom Q1 Non-GAAP Earnings, Revenue Rise; 2024 Revenue Guidance Gains; Shares Fall After Hours, from 4:43PM ET on Thursday Apr 25, 2024 by MT Newswires
  4:43PM ET on Thursday Apr 25, 2024 by MT Newswires
  Companies Mentioned: DXCM
- -- Earnings Flash (DXCM) DEXCOM Posts Q1 EPS $0.32, vs. Street Est of $0.27, from 4:05PM ET on Thursday Apr 25, 2024 by MT Newswires
  4:05PM ET on Thursday Apr 25, 2024 by MT Newswires
  Companies Mentioned: DXCM

IDEXX Laboratories Inc
NASDAQ:IDXXUnited States

Search Criteria

Today

BofA Securities Cuts Price Target on IDEXX Laboratories to $595 From $600, Maintains Neutral Rating, from 38 minutes ago by MT Newswires

Apr 4, 2024

Press Release: IDEXX Laboratories to Release 2024 First Quarter Financial Results, from 4:35PM ET on Thursday Apr 04, 2024 by Dow Jones

IDEXX Laboratories to Release 2024 First Quarter Financial Results, from 4:30PM ET on Thursday Apr 04, 2024 by Business Wire

IDEXX Laboratories to Release 2024 First Quarter Financial Results, from 4:30PM ET on Thursday Apr 04, 2024 by Dow Jones

Peers Headlines

Today

West to Participate in Upcoming Investor Conference, from 4 hours ago by PR Newswire

Apr 26, 2024

UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating, from 11:34AM ET on Friday Apr 26, 2024 by MT Newswires

Morgan Stanley Adjusts DexCom's Price Target to $132 From $122, from 11:08AM ET on Friday Apr 26, 2024 by MT Newswires

Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423, from 10:56AM ET on Friday Apr 26, 2024 by MT Newswires

Canaccord Genuity Adjusts Price Target on DexCom to $145 From $144, from 10:53AM ET on Friday Apr 26, 2024 by MT Newswires

Raymond James Adjusts DexCom Price Target to $160 From $151, from 10:25AM ET on Friday Apr 26, 2024 by MT Newswires

Align Technology to Buy Back $150 Million in Shares, from 10:05AM ET on Friday Apr 26, 2024 by MT Newswires

Align Technology Announces $150 Million Open Market Repurchase, from 8:30AM ET on Friday Apr 26, 2024 by Business Wire

Apr 25, 2024

DexCom Q1 Non-GAAP Earnings, Revenue Rise; 2024 Revenue Guidance Gains; Shares Fall After Hours, from 4:43PM ET on Thursday Apr 25, 2024 by MT Newswires

-- Earnings Flash (DXCM) DEXCOM Posts Q1 EPS $0.32, vs. Street Est of $0.27, from 4:05PM ET on Thursday Apr 25, 2024 by MT Newswires